New Clinical Trials Centre Cera The centre for eye research australia’s new clinical trial centre – cerulea clinical trials – is now open on level 7 of the royal victorian eye and ear hospital. trial participants can take the blue lifts up to the cerulea’s reception. we are no longer seeing participants at eye and ear on the park. Gene and stem cell therapies cerulea, a fully owned not for profit subsidiary of cera, is supported by a $10 million investment from breakthrough victoria. the new clinical trial centre – which will be located at the royal victorian eye and ear hospital – will open in 2024.
New Clinical Trials Centre Cera The state of the art clinical trial center, slated to open in 2024 at the royal victorian eye and ear hospital, aims to specialize in testing new gene and cell therapies, as well as other advanced therapeutics. The new eye clinical trials centre will be embedded in cera, which is co‑located with the university of melbourne department of surgery (ophthalmology) at the royal victorian eye and ear hospital. Breakthrough victoria is investing $10 million towards a new world leading eye clinical trials centre that will provide victorians with early access to new treatments aiming to prevent and cure blindness. The centre for eye research australia (cera) has launched a new specialist ophthalmic clinical trial facility, cerulea clinical trials, in victoria to coincide with the world clinical trials day.
Cerulea Clinical Trials Cera Breakthrough victoria is investing $10 million towards a new world leading eye clinical trials centre that will provide victorians with early access to new treatments aiming to prevent and cure blindness. The centre for eye research australia (cera) has launched a new specialist ophthalmic clinical trial facility, cerulea clinical trials, in victoria to coincide with the world clinical trials day. To mark world clinical trials day, victorian deputy premier and minister for medical research, the hon ben carroll, launched cerulea clinical trials – a new specialist ophthalmic clinical trial facility established by the centre for eye research australia (cera). In a significant stride for ophthalmic research, a new clinical trial centre, cerulea clinical trials, was recently launched in melbourne by victorian deputy premier and minister for medical research, the hon ben carroll. The new eye clinical trials centre will be embedded in cera, which is co located with the university of melbourne department of surgery (ophthalmology) at the royal victorian eye and ear hospital. Cerulea, a fully owned not for profit subsidiary of cera, is supported by a $10 million investment from breakthrough victoria. the new clinical trial centre, to be located at the royal victorian eye and ear hospital, will open in 2024.
Comments are closed.